期刊
JOURNAL OF CLINICAL DENSITOMETRY
卷 19, 期 1, 页码 102-116出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jocd.2015.11.003
关键词
Bone Health ECHO; emerging; osteoporosis; Project ECHO; treatment
资金
- NPS
- Novartis
- Amgen
- Genzyme
- Eli Lilly
- Merck
- Lilly
- Merck Serono
- Boehringer Ingelheim
- Roche Diagnostics
- Takeda
- University of Alabama
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109008] Funding Source: NIH RePORTER
The 2015 Santa Fe Bone Symposium was a venue for healthcare professionals and clinical researchers to present and discuss the clinical relevance of recent advances in the science of skeletal disorders, with a focus on osteoporosis and metabolic bone disease. Symposium topics included new developments in the translation of basic bone science to improved patient care, osteoporosis treatment duration, pediatric bone disease, update of fracture risk assessment, cancer treatment-related bone loss, fracture liaison services, a review of the most significant studies of the past year, and the use of telementoring with Bone Health Extension for Community Healthcare Outcomes, a force multiplier to improve the care of osteoporosis in underserved communities.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据